High-potentiality preliminary selection criteria and transformation time-dependent factors analysis for establishing Epstein-Barr virus transformed human lymphoblastoid cell lines

Cell Proliferation

Volumn 39, Issue 6, 2006, Pages 457-469

  Chang, I C ^a   Wu, J Y ^b   Lu, H I ^a   Ko, H W ^a   Kuo, J L ^a   Wang, C Y ^a   Shen, P S ^c   Hwang, S M ^a  

^a FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DENSITY; CELL TRANSFORMATION; CELL TRANSPORT; CELL VIABILITY; CRYOPRESERVATION; EPSTEIN BARR VIRUS; FACTORIAL ANALYSIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; NONHUMAN; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; CALLITHRIX; CELL COUNT; CELL LINE, TRANSFORMED; CELL SEPARATION; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; CRYOPRESERVATION; HERPESVIRUS 4, HUMAN; HUMANS;

HUMAN HERPESVIRUS 4;

EID: 33751024536     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2006.00404.x     Document Type: Article

References (24)

1. Beck JC, Beiswanger CM, Esther MJ, Satariano E, West D (2001) Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. Cancer Epidemiol. Biomarkers Prev. 10, 551-554.
2. Biddison WE (1998) Preparation and culture of human lymphocytes. In: Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J, Yamada KM, Morgan KS, eds. Current Protocols in Cell Biology, pp. 2.2.1-2.2.13. New York: John Wiley and Sons.
3. Borrebaeck CAK, Ohlin M (1996) In vitro immunization of peripheral lymphocytes. In: Doyle A, Griffiths JB, Newell DG, eds. Cell and Tissue Culture: Laboratory Procedures, p. 25E:1. New York: John Wiley and Sons.
4. Carter KL, Cahir-McFarland EE, Kieff E (2002) Epstein-Barr virus induced changes in B lymphocyte gene expression. J. Virol. 76, 10427-10436.
5. Cheng L, Wang LE, Spitz MR, Wei Q (2001) Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. Cancer Lett. 166, 155-163.
6. Fiebig EW, Johnson DK, Hirschkorn DF, Charlene C, Knape CC, Webster HK, Lowder J, Busch MP (1997) Lymphocyte subset analysis on frozen whole blood. Cytometry 29, 340-350.
7. Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC (2002) Whole blood cryopreservation in epidemiological studies. Cancer Epidemiol. Biomarkers Prev. 11, 1496-1498.
8. Heidemarie N (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet 73, 320-326.
9. Hollander M, Wolfe DA (1999) Nonparametric Statistical Methods. New York: Wiley.
10. Hur DY, Lee Mh, Kim JW, Kim JH, Shin YK, Rho JK, Kwack KB, Lee WJ, Han BG (2005) CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell. Cell Prolif. 38, 35-45.
11. Kalbfleisch JD, Prentice RL (2002) The Statistical Analysis of Failure Time Data. New York: Wiley.
12. Kilger E, Kieser A, Baumann M, Hammerschmidt W (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709.
13. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV (1999) Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin. Diagn. Lab. Immunol. 6, 14-19.
14. Martin DR, Robert L, Marlowe RL, Ahearn JM (1994) Determination of the role for CD21 during Epstein-Barr virus infection of B lymphoblastoid cells. J. Virol. 68, 4716-4726.
15. Mello AS, Burin MG, Michellin K, Viapiana M, Giugliani R, Coelho JC, Bauer ME (2006) Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders-enumerative conditions for cryopreservation. Cell Prolif. 39, 29-36.
16. Oh HM, Oh JM, Choi SC, Kim SW, Han WC, Kim TH, Park DS, Jun CD (2003) An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif. 36, 191-197.
17. Pan WH, Fang CSJ, Wu JY, Hung SI, Hung YT, Chen YJ, Hsu CL, Liao CJ, Chen YT (2004) Establishment of Taiwan Han Chinese cell and gene bank: comparing SNP profiles in MHC region with Caucasians. The 54th Annual Meeting of the American Society of Human Genetics. Canada: Toronto.
18. Penno MB, Pedrotti-Krueger M, Ray T (1993) Cryopreservation of whole blood and isolated lymphocytes for B-cell transformation. J. Tissue Culture Meth. 15, 43-48.
19. Raff HV, Wolff EA, Donaldson K (1996) Epstein-Barr virus transformation. In: Doyle A, Griffiths JB, Newell DG, eds. Cell and Tissue Culture: Laboratory Procedures, p. 25E:3. New York: John Wiley & Sons.
20. Sarrias MR, Franchini S, Canziani G, Argyropoulos E, Moore WT, Sahu A, Lambris JD (2001) Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b and the EBV glycoprotein gp350/ 2201. J. Immunol. 167, 1490-1499.
21. Sinclair AJ, Farrell PJ (1995) Host cell requirements for efficient infection of quiescent primary b lymphocytes by Epstein-Barr virus. J. Virol. 69, 5461-5468.
22. Tosato G, Pike SE, Koski IR, Blaese RM (1982) Selective inhibition of immunoregulatory cell functions by cyclosporine A. J. Imunol. 128, 1986.
23. Tremblay S, Khandjian EW (1998) Successful use of long-term frozen lymphocytes for the establishment of lymphoblastoid cell lines. Clin. Biochem. 31, 555-556.
24. Yang L, Maruo S, Takada K (2000) CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells. J. Virol. 74, 10745-10751.